Related Experiment Videos
Improvement predictors in obsessive-compulsive disorder. An event-related potential study
P Morault1, F Guillem, M Bourgeois
1Unité d'Investigations Cliniques Approfondies, Hôpital Ch. Perrens, and Université de Bordeaux 2, France. morault@physio.u-bordeaux2.fr
Psychiatry Research
|November 26, 1998
Summary
Predicting obsessive-compulsive disorder (OCD) treatment response is challenging. Pre-treatment event-related potentials (ERPs) abnormalities, specifically reduced N2 amplitude and shorter N2/P3 latencies, may predict medication efficacy in OCD patients.
Area of Science:
- Neuroscience
- Psychiatry
- Clinical Psychology
Background:
- Obsessive-compulsive disorder (OCD) treatment outcomes vary significantly.
- Predicting medication response in OCD patients remains a clinical challenge.
- Previous research suggests pre-treatment event-related potentials (ERPs) may correlate with treatment efficacy.
Purpose of the Study:
- To validate the association between pre-treatment ERPs and treatment response in a larger OCD cohort.
- To identify specific ERP abnormalities as potential biomarkers for predicting treatment success in OCD.
Main Methods:
- Compared ERPs elicited during a verbal auditory 'oddball' paradigm in 21 unmedicated OCD patients and 21 controls.
- Analyzed pre-treatment ERP components (N2 amplitude, N2 and P3 latencies) retrospectively.
- Categorized patients into treatment responders (n=12) and non-responders based on pharmacological treatment outcome.
Main Results:
- Treatment responders exhibited significantly reduced N2 amplitude compared to non-responders and controls.
- Responders also showed significantly shorter N2 and P3 latencies than non-responders and controls.
- No significant ERP differences were found between non-responders and control subjects.
Conclusions:
- Abnormalities in pre-treatment ERPs, specifically N2 amplitude and N2/P3 latencies, are associated with favorable treatment response in OCD.
- These ERP findings suggest potential utility as predictive biomarkers for medication efficacy in OCD.
- Further prospective studies are warranted to confirm these predictive relationships.